Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature Review
  • Published:

Molecular genetics of autism spectrum disorder

Molecular Psychiatry volume 9, pages 819–832 (2004)Cite this article

Abstract

We are on the brink of exciting discoveries into the molecular genetic underpinnings of autism spectrum disorder. Overwhelming evidence of genetic involvement coupled with increased societal attention to the disorder has drawn in more researchers and more research funding. Autism is a strongly genetic yet strikingly complex disorder, in which evidence from different cases supports chromosomal disorders, rare single gene mutations, and multiplicative effects of common gene variants. With more and more interesting yet sometimes divergent findings emerging every year, it is tempting to view these initial molecular studies as so much noise, but the data have also started to coalesce in certain areas. In particular, recent studies in families with autism spectrum disorder have identified uncommon occurrences of a novel genetic syndrome caused by disruptions of the NLGN4 gene on chromosome Xp22. Previous work had identified another uncommon syndrome that is caused by maternal duplications of the chromosome 15q11–13 region. We highlight other converging findings, point toward those areas most likely to yield results, and emphasize the contributions of multiple approaches to identifying the genes of interest.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (4th ed.). American Psychiatric Association Press, Inc: Washington, DC, 1994.

  2. Filipek PA, Accardo PJ, Baranek GT, Cook Jr EH, Dawson G, Gordon B et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29: 439–484.

    Article  CAS  PubMed  Google Scholar 

  3. Constantino JN, Todd RD . Autistic traits in the general population: a twin study. Arch Gen Psychiatry 2003; 60: 524–530.

    Article  PubMed  Google Scholar 

  4. Chakrabarti S, Fombonne E . Pervasive developmental disorders in preschool children. JAMA 2001; 285: 3093–3099.

    Article  CAS  PubMed  Google Scholar 

  5. Fombonne E . The prevalence of autism. JAMA 2003; 289: 87–89.

    Article  PubMed  Google Scholar 

  6. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63–78.

    Article  CAS  PubMed  Google Scholar 

  7. Jorde L, Hasstedt S, Ritvo E, Mason-Brothers A, Freeman B, Pingree C et al. Complex segregation analysis of autism. Am J Hum Genet 1991; 49: 932–938.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Cuccaro ML, Shao Y, Bass MP, Abramson RK, Ravan SA, Wright HH et al. Behavioral comparisons in autistic individuals from multiplex and singleton families. J Autism Dev Disord 2003; 33: 87–91.

    Article  PubMed  Google Scholar 

  9. Pritchard JK, Cox NJ . The allelic architecture of human disease genes: common disease–common variant. or not? Hum Mol Genet 2002; 11: 2417–2423.

    Article  CAS  PubMed  Google Scholar 

  10. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 1998; 7: 571–578.

  11. Collaborative Linkage Study of Autism (CLSA). An autosomal genomic screen for autism. Am J Med Genet 1999; 88: 609–615.

  12. Liu J, Nyholt D, Magnussen P, Parano E, Pavone P, Geschwind D et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001; 69: 327–340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ashley-Koch A, Wolpert CM, Menold MM, Zaeem L, Basu S, Donnelly SL et al. Genetic studies of autistic disorder and chromosome 7. Genomics 1999; 61: 227–236.

    Article  CAS  PubMed  Google Scholar 

  14. International Molecular Genetic Study of Autism Consortium. A genome wide screen for autism: strong evidence for linkage to chromosomes 2q, 7q and 16p. Am J Hum Genet 2001; 69: 570–581.

  15. Badner J, Gershon E . Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Mol Psychiatry 2002; 7: 56–66.

    Article  CAS  PubMed  Google Scholar 

  16. Vincent JB, Herbrick JA, Gurling HM, Bolton PF, Roberts W, Scherer SW . Identification of a novel gene on chromosome 7q31 that is interrupted by a translocation breakpoint in an autistic individual. Am J Hum Genet 2000; 67: 510–514.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Warburton P, Baird G, Chen W, Morris K, Jacobs B, Hodgson S et al. Support for linkage of autism and specific language impairment to 7q3 from two chromosome rearrangements involving band 7q31. Am J Med Genet 2000; 96: 228–234.

    Article  CAS  PubMed  Google Scholar 

  18. Tentler D, Brandberg G, Betancur C, Gillberg C, Anneren G, Orsmark C et al. A balanced reciprocal translocation t(5;7)(q14;q32) associated with autistic disorder: molecular analysis of the chromosome 7 breakpoint. Am J Med Genet 2001; 105: 729–736.

    Article  CAS  PubMed  Google Scholar 

  19. Vincent J, Petek E, Thevarkunnel S, Kolozsvari D, Cheung J, Patel M et al. The RAY1/ST7 tumor-suppressor locus on chromosome 7q31 represents a complex multi-transcript system. Genomics 2002; 80: 283.

    Article  CAS  PubMed  Google Scholar 

  20. Cisternas FA, Vincent JB, Scherer SW, Ray PN . Cloning and characterization of human CADPS and CADPS2, new members of the Ca2+-dependent activator for secretion protein family. Genomics 2003; 81: 279–291.

    Article  CAS  PubMed  Google Scholar 

  21. Bonora E, Bacchelli E, Levy ER, Blasi F, Marlow A, Monaco A et al. Mutation screening and imprinting analysis of four candidate genes for autism in the 7q32 region. Mol Psychiatry 2002; 7: 289–301.

    Article  CAS  PubMed  Google Scholar 

  22. Cheung J, Petek E, Nakabayashi K, Tsui LC, Vincent JB, Scherer SW . Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31. Genomics 2001; 78: 7–11.

    Article  CAS  PubMed  Google Scholar 

  23. Persico A, Militerni R, Bravaccio C, Schneider C, Melmed R, Trillo S et al. No association between the 4g/5G polymorphism of the plasminogen activator inhibitor-1 gene promoter and autistic disorder. Psychiatr Genet 2001; 11: 99–103.

    Article  CAS  PubMed  Google Scholar 

  24. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP . A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001; 413: 519–523.

    Article  CAS  PubMed  Google Scholar 

  25. Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G et al. FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet 2002; 70: 1318–1327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, Folstein SE et al. Evaluation of FOXP2 as an autism susceptibility gene. Am J Med Genet 2002; 114: 566–569.

    Article  PubMed  Google Scholar 

  27. O’Brien EK, Zhang X, Nishimura C, Tomblin JB, Murray JC . Association of specific language impairment (SLI) to the region of 7q31. Am J Hum Genet 2003; 72: 1536–1543.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lijam N, Paylor R, McDonald M, Crawley J, Deng C-X, Herrup K et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 1997; 90: 895–905.

    Article  CAS  PubMed  Google Scholar 

  29. Wassink T, Piven J, Vieland V, Huang J, Swiderski R, Pietila J et al. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 406–413.

    Article  CAS  Google Scholar 

  30. McCoy PA, Shao Y, Wolpert CM, Donnelly SL, Ashley-Koch A, Abel HL et al. No association between the WNT2 gene and autistic disorder. Am J Med Genet 2002; 114: 106–109.

    Article  PubMed  Google Scholar 

  31. Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N et al. Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet (Neuropsychiatr Genet) 2004; 126: 51–57.

    Article  Google Scholar 

  32. Fatemi SH, Stary JM, Halt AR, Realmuto GR . Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 2001; 31: 529–535.

    Article  CAS  PubMed  Google Scholar 

  33. Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 2000; 26: 93–96.

    Article  CAS  PubMed  Google Scholar 

  34. Persico A, D’Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 2001; 6: 150–159.

    Article  CAS  PubMed  Google Scholar 

  35. Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR et al. Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 2002; 7: 1012–1017.

    Article  CAS  PubMed  Google Scholar 

  36. Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M . Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 2002; 7: 801–804.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W et al. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA Network. Am J Med Genet (Neuropsychiatr Genet) 2004; 126: 46–50.

    Article  Google Scholar 

  38. Bonora E, Beyer K, Lamb J, Parr J, Klauck S, Benner A et al. Analysis of reelin as a candidate gene for autism. Mol Psychiatry 2003; 8: 885–892.

    Article  CAS  PubMed  Google Scholar 

  39. Nurmi EL, Dowd M, Tadevosyan-Leyfer O, Haines JL, Folstein SE, Sutcliffe JS . Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11–q13. J Am Acad Child Adolesc Psychiatry 2003; 42: 856–863.

    Article  PubMed  Google Scholar 

  40. Cook E, Lindgren V, Leventhal B, Courchesne R, Lincoln A, Shulman C et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997; 60: 928–934.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M et al. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 1998; 76: 327–336.

    Article  CAS  PubMed  Google Scholar 

  42. Bolton PF, Dennis NR, Browne CE, Thomas NS, Veltman MWM, Thompson RJ et al. The phenotypic manifestations of interstitial duplications of proximal 15q, with special reference to the autistic spectrum disorders. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 675–685.

    Article  CAS  Google Scholar 

  43. Thomas JA, Johnson J, Peterson Kraai TL, Wilson R, Tartaglia N, LeRoux J et al. Genetic and clinical characterization of patients with an interstitial duplication 15q11–q13, emphasizing behavioral phenotype and response to treatment. Am J Med Genet 2003; 119A: 111–120.

    Article  CAS  PubMed  Google Scholar 

  44. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997; 15: 74–77.

    Article  CAS  PubMed  Google Scholar 

  45. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M . Autism in Angelman syndrome: a population-based study. Pediatr Neurol 1996; 14: 131–136.

    Article  CAS  PubMed  Google Scholar 

  46. Moncla A, Malzac P, Voelckel MA, Auquier P, Girardot L, Mattei MG et al. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. Eur J Hum Genet 1999; 7: 131–139.

    Article  CAS  PubMed  Google Scholar 

  47. Herzing LB, Cook Jr EH, Ledbetter DH . Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11–q13 duplications. Hum Mol Genet 2002; 11: 1707–1718.

    Article  CAS  PubMed  Google Scholar 

  48. Herzing LB, Kim SJ, Cook Jr EH, Ledbetter DH . The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression. Am J Hum Genet 2001; 68: 1501–1505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Meguro M, Kashiwagi A, Mitsuya K, Nakao M, Kondo I, Saitoh S et al. A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nat Genet 2001; 28: 19–20.

    CAS  PubMed  Google Scholar 

  50. Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K . The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet 2001; 10: 2687–2700.

    Article  CAS  PubMed  Google Scholar 

  51. Veenstra-VanderWeele J, Gonen D, Leventhal BL, Cook Jr EH . Mutation screening of the UBE3A/E6-AP gene in autistic disorder. Mol Psychiatry 1999; 4: 64–67.

    Article  CAS  PubMed  Google Scholar 

  52. Kim S-J, Herzing LBK, Veenstra-VanderWeele J, Lord C, Courchesne R, Leventhal BL et al. Mutation screening and transmission disequilibrium study of ATP10C in autism. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 137–143.

    Article  Google Scholar 

  53. Nurmi EL, Bradford Y, Chen Y, Hall J, Arnone B, Gardiner MB et al. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 2001; 77: 105–113.

    Article  CAS  PubMed  Google Scholar 

  54. Nurmi EL, Amin T, Olson LM, Jacobs MM, McCauley JL, Lam AY et al. Dense linkage disequilibrium mapping in the 15q11–q13 maternal expression domain yields evidence for association in autism. Mol Psychiatry 2003; 8: 624–634, 570..

    Article  CAS  PubMed  Google Scholar 

  55. Cook Jr EH, Courchesne RY, Cox NJ, Lord C, Gonen D, Guter SJ et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11–13 markers. Am J Hum Genet 1998; 62: 1077–1083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Buxbaum J, Silverman J, Smith C, Greenberg D, Kilifarski M, Reichert J et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 2002; 7: 311–316.

    Article  CAS  PubMed  Google Scholar 

  57. Martin ER, Menold MM, Wolpert CM, Bass MP, Donnelly SL, Ravan SA et al. Analysis of linkage disequilibrium in γ-aminobutyric acid receptor subunit genes in autistic disorder. Am J Med Genet (Neuropsychiatr Genet) 2000; 96: 43–48.

    Article  Google Scholar 

  58. Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E et al. Genome-wide scan for autism susceptibility genes. Hum Mol Genet 1999; 8: 805–812.

    Article  CAS  PubMed  Google Scholar 

  59. Shao Y, Wolpert C, Raiford K, Menold M, Donnelly S, Ravan S et al. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 99–105.

    Article  Google Scholar 

  60. Waage-Baudet H, Lauder JM, Dehart DB, Kluckman K, Hiller S, Tint GS et al. Abnormal serotonergic development in a mouse model for the Smith–Lemli–Opitz syndrome: implications for autism. Int J Dev Neurosci 2003; 21: 451–459.

    Article  CAS  PubMed  Google Scholar 

  61. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Thomas NS, Sharp AJ, Browne CE, Skuse D, Hardie C, Dennis NR . Xp deletions associated with autism in three females. Hum Genet 1999; 104: 43–48.

    Article  CAS  PubMed  Google Scholar 

  63. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T . Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000; 101: 657–669.

    Article  CAS  PubMed  Google Scholar 

  64. Rao A, Harms KJ, Craig AM . Neuroligation: building synapses around the neurexin-neuroligin link. Nat Neurosci 2000; 3: 747–749.

    Article  CAS  PubMed  Google Scholar 

  65. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP et al. X-Linked mental retardation and autism are associated with a mutation in the NLGN4 Gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552–557.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY . Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185–188.

    Article  CAS  PubMed  Google Scholar 

  67. Chen RZ, Akbarian S, Tudor M, Jaenisch R . Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001; 27: 327–331.

    Article  CAS  PubMed  Google Scholar 

  68. Guy J, Hendrich B, Holmes M, Martin JE, Bird A . A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001; 27: 322–326.

    Article  CAS  PubMed  Google Scholar 

  69. Shahbazian M, Antalffy B, Armstrong D, Zoghbi H . Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002; 11: 115–124.

    Article  CAS  PubMed  Google Scholar 

  70. Jin P, Warren ST . Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000; 9: 901–908.

    Article  CAS  PubMed  Google Scholar 

  71. Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ . Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 2001; 98: 7101–7106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Huber KM, Gallagher SM, Warren ST, Bear MF . Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002; 99: 7746–7750.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Skuse D, James R, Bishop D, Coppin B, Dalton P, Aamodt-Leeper G et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997; 387: 705–708.

    Article  CAS  PubMed  Google Scholar 

  74. Nystrom-Lahti M, Parsons R, Sistonen P, Pylkkanen L, Aaltonen LA, Leach FS et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994; 55: 659–665.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–892.

    Article  PubMed  PubMed Central  Google Scholar 

  76. The Cystic Fibrosis Genotype–Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308–1313.

  77. Zappella M, Meloni I, Longo I, Canitano R, Hayek G, Rosaia L et al. Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet 2003; 119B: 102–107.

    Article  PubMed  Google Scholar 

  78. Lord C, Rutter M, Le Couteur A . Autism diagnostic interview—revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659–685.

    Article  CAS  PubMed  Google Scholar 

  79. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989; 19: 185–212.

    Article  CAS  PubMed  Google Scholar 

  80. Pickles A, Starr E, Kazak S, Bolton P, Papanikolaou K, Bailey A et al. Variable expression of the autism broader phenotype: findings from extended pedigrees. J Child Psychol Psychiatry 2000; 41: 491–502.

    Article  CAS  PubMed  Google Scholar 

  81. Piven J, Palmer P . Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families. Am J Psychiatry 1999; 156: 557–563.

    CAS  PubMed  Google Scholar 

  82. Gottesman II, Gould TD . The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636–645.

    Article  PubMed  Google Scholar 

  83. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002; 59: 1085–1096.

    Article  CAS  PubMed  Google Scholar 

  84. Kanner L . Autistic disturbances of affective contact. Nerv Child 1943; 2: 217–250.

    Google Scholar 

  85. Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997; 36: 282–290.

    Article  CAS  PubMed  Google Scholar 

  86. Fombonne E, Roge B, Claverie J, Courty S, Fremolle J . Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999; 29: 113–119.

    Article  CAS  PubMed  Google Scholar 

  87. Courchesne E, Carper R, Akshoomoff N . Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290: 337–344.

    Article  PubMed  Google Scholar 

  88. Schain RJ, Freedman DX . Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961; 58: 315–320.

    Article  CAS  PubMed  Google Scholar 

  89. Cook E, Leventhal B . The serotonin system in autism. Curr Opin Pediatr 1996; 8: 348–354.

    Article  CAS  PubMed  Google Scholar 

  90. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997; 42: 666–669.

    Article  CAS  PubMed  Google Scholar 

  91. Chugani DC, Muzik O, Chakraborty P, Mangner T, Chugani HT . Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse 1998; 28: 33–43.

    Article  CAS  PubMed  Google Scholar 

  92. Weiss LA, Veenstra-VanderWeele J, Abney M, Newman DL, Kim S-J, Dytch H et al. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet, in press.

  93. Sultana R, Yu C, Yu J, Munson J, Chen D, Hua W et al. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics 2002; 80: 129.

    Article  CAS  PubMed  Google Scholar 

  94. Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet 2003; 40: 352–356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Ishikawa-Brush Y, Powell J, Bolton P, Miller A, Francis F, Willard H et al. Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3′ to the SDC2 gene. Hum Mol Genet 1997; 6: 1241–1250.

    Article  CAS  PubMed  Google Scholar 

  96. Borg I, Squire M, Menzel C, Stout K, Morgan D, Willatt L et al. A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation. J Med Genet 2002; 39: 391–399.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Martin CL, Ilkin Y, Powell C, Rao K, Whichello A, Cook E . Breakpoint mapping of a de novo 15p;16p translocation reveals a candidate gene for autism. Am J Hum Genet 2003; 73: 325S.

    Article  Google Scholar 

  98. Yu CE, Dawson G, Munson J, D’Souza I, Osterling J, Estes A et al. Presence of large deletions in kindreds with autism. Am J Hum Genet 2002; 71: 100–115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Badner JA, Gershon ES, Goldin LR . Optimal ascertainment strategies to detect linkage to common disease alleles. Am J Hum Genet 1998; 63: 880–888.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493–507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Ober C, Abney M, McPeek MS . The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001; 69: 1068–1079.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV et al. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002; 296: 739–741.

    Article  CAS  PubMed  Google Scholar 

  103. Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T et al. A genomewide screen for autism–spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 2002; 71.

  104. Buxbaum JD, Silverman JM, Smith CJ, Kilifarski M, Reichert J, Hollander E et al. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 2001; 68: 1514–1520.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003; 73: 886–897.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Shao Y, Raiford KL, Wolpert CM, Cope HA, Ravan SA, Ashley-Koch AA et al. Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder. Am J Hum Genet 2002; 70: 1058–1061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Bradford Y, Haines J, Hutcheson H, Gardiner M, Braun T, Sheffield V et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001; 105: 539–547.

    Article  CAS  PubMed  Google Scholar 

  108. Alarcón M, Cantor R, Liu J, Gilliam T, Autism Genetic Resource Exchange Consortium, Geschwind D . Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002; 70: 60–71.

    Article  PubMed  Google Scholar 

  109. Bacanu S-A, Devlin B, Roeder K . The power of genomic control. Am J Hum Genet 2000; 66: 1933–1944.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Pritchard JK, Donnelly P . Case–control studies of association in structured or admixed populations. Theor Pop Biol 2001; 60: 227–237.

    Article  CAS  Google Scholar 

  111. Abney M, Ober C, McPeek MS . Quantitative trait homozygosity and association mapping and empirical genome-wide significance in large complex pedigrees: fasting serum insulin levels in the Hutterites. Am J Hum Genet 2002; 70: 920–934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Risch N, Merikangas K . The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517.

    Article  CAS  PubMed  Google Scholar 

  113. Zabetian CP, Buxbaum SG, Elston RC, Kohnke MD, Anderson GM, Gelernter J et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 2003; 72: 1389–1400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Morris RW, Kaplan NL . On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221–233.

    Article  PubMed  Google Scholar 

  115. Wall JD, Pritchard JK . Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 2003; 4: 587–597.

    Article  CAS  PubMed  Google Scholar 

  116. Cook Jr EH, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2: 247–250.

    Article  PubMed  Google Scholar 

  117. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.

    Article  CAS  PubMed  Google Scholar 

  118. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.

    Article  CAS  PubMed  Google Scholar 

  119. Fiskerstrand CE, Lovejoy EA, Quinn JP . An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 1999; 458: 171–174.

    Article  CAS  PubMed  Google Scholar 

  120. MacKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer- like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251–15255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Kim S-J, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N et al. Transmission disequilibrium mapping in the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 2002; 7: 278–288.

    Article  CAS  PubMed  Google Scholar 

  122. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L . The serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 2004; 9: 587–593.

    Article  CAS  PubMed  Google Scholar 

  123. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD et al. Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet (Neuropsychiatr Genet) 2003; 127: 104–112.

    Google Scholar 

  124. Klauck SM, Poustka F, Benner A, Lesch K-P, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997; 6: 2233–2238.

    Article  CAS  PubMed  Google Scholar 

  125. Tordjman S, Gutneckt L, Carlier M, Spitz E, Antoine C, Slama F et al. Role of the serotonin transporter in the behavioral expression of autism. Mol Psychiatry 2001; 6: 434–439.

    Article  CAS  PubMed  Google Scholar 

  126. Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 381–386.

    Article  CAS  Google Scholar 

  127. Maestrini E, Lai C, Marlow A, Matthews N, Wallace S, Bailey A et al. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. Am J Med Genet 1999; 88: 492–496.

    Article  CAS  PubMed  Google Scholar 

  128. Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M et al. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet 2000; 96: 123–127.

    Article  CAS  PubMed  Google Scholar 

  129. Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C et al. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004; 9: 264–271.

    Article  CAS  PubMed  Google Scholar 

  130. Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche J-L, Launay J-M et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 2002; 7: 67–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 2002; 7: 67–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P et al. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 2002; 7: 831–836.

    Article  CAS  PubMed  Google Scholar 

  133. Persico AM, Pascucci T, Puglisi-Allegra S, Militerni R, Bravaccio C, Schneider C et al. Serotonin transporter gene promoter variants do not explain the hyperserotonemia in autistic children. Mol Psychiatry 2002; 7: 795–800.

    Article  CAS  PubMed  Google Scholar 

  134. Ozaki N, Goldman D, Kaye W, Plotnikov K, Greenberg B, Rudnick G et al. A missense mutation in the serotonin transporter is associated with a complex neuropsychiatric phenotype. Mol Psychiatry 2003; 8: 933–936.

    Article  CAS  PubMed  Google Scholar 

  135. Glatt C, DeYoung J, Delgado S, Service S, Giacomini K, Edwards R et al. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 2001; 27: 435–438.

    Article  CAS  PubMed  Google Scholar 

  136. Nakamura M, Ueno S, Sano A, Tanabe H . The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5: 32–38.

    Article  CAS  PubMed  Google Scholar 

  137. Ramoz N, Reichert J, Smith C, Silverman J, Bespalova I, Davis K et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004; 161: 662–669.

    Article  PubMed  Google Scholar 

  138. Contractor A, Swanson G, Heinemann SF . Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron 2001; 29: 209–216.

    Article  CAS  PubMed  Google Scholar 

  139. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002; 7: 302–310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Kim SJ, Young LJ, Gonen D, Veenstra-VanderWeele J, Courchesne R, Courchesne E et al. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry 2002; 7: 503–507.

    Article  CAS  PubMed  Google Scholar 

  141. Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM . Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology 2000; 62: 393–405.

    Article  CAS  PubMed  Google Scholar 

  142. Devlin B, Bennett P, Cook Jr EH, Dawson G, Gonen D, Grigorenko EL et al. No evidence for linkage of liability to autism to HOXA1 in a sample from the CPEA network. Am J Med Genet 2002; 114: 667–672.

    Article  PubMed  Google Scholar 

  143. Li J, Tabor HK, Nguyen L, Gleason C, Lotspeich LJ, Spiker D et al. Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families. Am J Med Genet 2002; 114: 24–30.

    Article  PubMed  Google Scholar 

  144. Romano V, Cali F, Mirisola M, Gambino G, R DA, Di Rosa P et al. Lack of association of HOXA1 and HOXB1 mutations and autism in Sicilian (Italian) patients. Mol Psychiatry 2003; 8: 716–717.

    Article  CAS  PubMed  Google Scholar 

  145. Gallagher L, Hawi Z, Kearney G, Fitzgerald M, Gill M . No association between allelic variants of HOXA1/HOXB1 and autism. Am J Med Genet (Neuropsychiatr Genet) 2004; 124B: 64–67.

    Article  Google Scholar 

  146. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT . Social amnesia in mice lacking the oxytocin gene. Nat Genet 2000; 25: 284–288.

    Article  CAS  PubMed  Google Scholar 

  147. Young LJ, Nilsen R, Waymire KG, MacGregor GR, Insel TR . Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature 1999; 400: 766–768.

    Article  CAS  PubMed  Google Scholar 

  148. Wu C-T, Morris JR . Genes, genetics, and epigenetics: a correspondence. Science 2000; 239: 1103–1105.

    Google Scholar 

  149. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003; 361: 1693–1699.

    Article  CAS  PubMed  Google Scholar 

  150. Rakyan VK, Preis J, Morgan HD, Whitelaw E . The marks, mechanisms and memory of epigenetic states in mammals. Biochem J 2001; 356: 1–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Waterland RA, Jirtle RL . Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293–5300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Blatt G, Fitzgerald C, Guptill J, Booker A, Kemper T, Bauman M . Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 2001; 31: 537–543.

    Article  CAS  PubMed  Google Scholar 

  153. Fatemi S, Halt A, Stary J, Kanodia R, Schulz S, Realmuto G . Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 2002; 52: 805.

    Article  CAS  PubMed  Google Scholar 

  154. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001; 158: 1058–1066.

    Article  CAS  PubMed  Google Scholar 

  155. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002; 125: 1483–1495.

    Article  CAS  PubMed  Google Scholar 

  156. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J . Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001; 57: 1618–1628.

    Article  CAS  PubMed  Google Scholar 

  157. Fatemi SH, Halt AR . Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse 2001; 42: 281–284.

    Article  CAS  PubMed  Google Scholar 

  158. Fatemi SH, Halt AR, Stary JM, Realmuto GM, Jalali-Mousavi M . Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum. Neuroreport 2001; 12: 929–933.

    Article  CAS  PubMed  Google Scholar 

  159. Purcell AE, Rocco MM, Lenhart JA, Hyder K, Zimmerman AW, Pevsner J . Assessment of neural cell adhesion molecule (NCAM) in autistic serum and postmortem brain. J Autism Dev Disord 2001; 31: 183–194.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Chicago, Chicago, IL, USA

    J Veenstra-VanderWeele

  2. Departments of Psychiatry, Pediatrics, and Human Genetics, University of Chicago, Chicago, IL, USA

    E H Cook Jr

Authors
  1. J Veenstra-VanderWeele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E H Cook Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E H Cook Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veenstra-VanderWeele, J., Cook, E. Molecular genetics of autism spectrum disorder. Mol Psychiatry 9, 819–832 (2004). https://doi.org/10.1038/sj.mp.4001505

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001505

Keywords

This article is cited by

Search

Advanced search

Quick links